Provided by Tiger Fintech (Singapore) Pte. Ltd.

Unicycive Therapeutics, Inc.

0.6299
+0.097818.38%
Post-market: 0.63000.0001+0.02%19:56 EDT
Volume:8.44M
Turnover:5.19M
Market Cap:75.98M
PE:-2.42
High:0.6480
Open:0.5849
Low:0.5780
Close:0.5321
Loading ...
Jun 10, 2025

Major Issues Report

Form 8-K - Current report
Jun 09, 2025

Major Issues Report

Form 8-K - Current report
May 21, 2025

Major Issues Report

Form 8-K - Current report
May 14, 2025

Major Issues Report

Form 8-K - Current report
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 14, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Apr 02, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 01, 2025

Major Issues Report

Form 8-K - Current report
Mar 31, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 07, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2024

Correspondence

Form CORRESP - Correspondence
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report